Medroxyprogesterone Acetate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70700-315 -
Package NDC
70700-315-25 -
Package NDC
70700-315-27 -
Application number
ANDA210227 -
SPL ID
1a9d4cef-846b-2f23-65e1-7d4d4231f1cc -
SPL set ID
24544a5d-0cf5-a099-b57c-6e0843a40532 -
UNII
C2QI4IOI2G -
RxCUI
1000126
What the source publishes
- Labeler
- Xiromed LLC
- Active ingredients
- Medroxyprogesterone Acetate
- Form
- INJECTION, SUSPENSION
- Routes
- INTRAMUSCULAR
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Medroxyprogesterone Acetate",
"splId": "1a9d4cef-846b-2f23-65e1-7d4d4231f1cc",
"labels": [
{
"setId": "24544a5d-0cf5-a099-b57c-6e0843a40532",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24544a5d-0cf5-a099-b57c-6e0843a40532",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=24544a5d-0cf5-a099-b57c-6e0843a40532"
}
],
"routes": [
"INTRAMUSCULAR"
],
"labeler": "Xiromed LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "25 VIAL in 1 CARTON (70700-315-25) / 1 mL in 1 VIAL (70700-315-22)",
"package_ndc": "70700-315-25",
"identifierStatus": "well-formed",
"marketing_start_date": "20240312"
},
{
"sample": false,
"description": "1 VIAL in 1 CARTON (70700-315-27) / 1 mL in 1 VIAL (70700-315-22)",
"package_ndc": "70700-315-27",
"identifierStatus": "well-formed",
"marketing_start_date": "20240312"
}
],
"productId": "70700-315_1a9d4cef-846b-2f23-65e1-7d4d4231f1cc",
"useDomain": "unknown",
"dosageForm": "INJECTION, SUSPENSION",
"productNdc": "70700-315",
"deaSchedule": null,
"genericName": "Medroxyprogesterone Acetate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MEDROXYPROGESTERONE ACETATE",
"strength": "150 mg/mL"
}
],
"applicationNumber": "ANDA210227",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240312",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"C2QI4IOI2G"
],
"rxcui": [
"1000126"
],
"spl_set_id": [
"24544a5d-0cf5-a099-b57c-6e0843a40532"
],
"manufacturer_name": [
"Xiromed LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70700-315_1a9d4cef-846b-2f23-65e1-7d4d4231f1cc"